10x Genomics Expands Leadership in Single Cell Analysis with

GEM-X, the next generation of the company's leading single cell technology architecture, enables higher performance at larger scale and lower cost
Pre-orders now open for first two Chromium products...

Related Keywords

, Michael Schnall Levin , Securities Exchange , Nasdaq , Exchange Commission , Linkedin , Genomics Inc , Founding Scientist , Chief Technology Officer , Chromium Single Cell Gene Expression , Chromium Single Cell Immune Profiling , Chromiumx Series , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act , Financial Condition , Markets ,